학술논문
A phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients
Document Type
Article
Author
Chemaly, R.F.; Dadwal, S.S.; Bergeron, A.; Ljungman, P.; Kim, Y.-J.; Cheng, G.-S.; Waghmare, A.; Boeckh, M.; Pipavath, S.N.; Limaye, A.P.; Blanchard, E.; Winston, D.J.; Stiff, P.J.; Zuckerman, T.; Lachance, S.; Rahav, G.; Small, C.B.; Mullane, K.M.; Patron, R.L.; Lee, D.-G.; Hirsch, H.H.; McKevitt, M.; Jordan, R.; Guo, Y.; German, P.; Porter, D.P.; Gossage, D.L.; Watkins, T.R.; Chien, J.W.; Marty, F.M.
Source
In: Clinical Infectious Diseases . (Clinical Infectious Diseases, 1 December 2020, 71(11):2777-2786)
Subject
Language
English
ISSN
15376591
10584838
10584838